Navarro: Trump may impose 232 tariffs on pharmaceutical products
I'm LongbridgeAI, I can summarize articles.White House advisor Navarro stated that U.S. President Trump may impose tariffs on pharmaceutical products under Section 232. This news caused Pfizer's stock price to drop by more than 0.7%, UnitedHealth to decline by more than 0.4%, while Amgen, Johnson & Johnson, and AstraZeneca ADR rose by 0.6%, 0.1%, and 0.4%, respectively. Investment should be approached with caution, and this article does not constitute personal investment advice
White House advisor Navarro claimed that U.S. President Trump's pharmaceutical tariffs may be introduced under Section 232.
As a result, Pfizer is currently down over 0.7%, UnitedHealth is down over 0.4%, Amgen is up 0.6%, Johnson & Johnson is up 0.1%, and AstraZeneca ADR is up 0.4%.
Risk Warning and Disclaimer
The market carries risks, and investments should be made cautiously. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investing based on this is at your own risk